Market Tracker

07/23 2:04pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

30.32
Data as of 1:43pm ET
 +0.57 / +1.92%
Today’s Change
27.51
Today|||52-Week Range
39.95
+3.84%
Year-to-Date

Today’s Trading

Previous close29.75
Today’s open30.04
Day’s range30.04 - 30.73
Volume205,649
Average volume (3 months)605,209
Market cap$1.2B
Dividend yield--
Data as of 1:43pm ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)+3.11%
Earnings growth (next 5 years)+30.50%
Revenue growth (last year)+10.01%
P/E ratio68.9
Price/Sales3.49
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.12+0.33%
KPTIKaryopharm Therapeut...-0.68-1.89%
LCILannett Company Inc-0.23-0.62%
CBPOChina Biologic Produ...+0.23+0.50%
Data as of 2:01pm ET, 07/23/2014

Financials

Next reporting dateAugust 5, 2014
EPS forecast (this quarter)$0.15
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts